|

Cannabis Use and Outcomes in Black and White Patients With Cancer

RECRUITINGSponsored by State University of New York at Buffalo
Actively Recruiting
SponsorState University of New York at Buffalo
Started2023-03-30
Est. completion2026-09-30
Eligibility
Age21 Years – 99 Years
Healthy vol.Accepted
Locations3 sites

Summary

The goal of the observational study is to learn how black and white patients with solid tumor cancer use cannabis, opioids and tobacco. The investigators are using momentary ecological assessment through a smart phone app and surveys to assess patient-reported pain and other symptoms as to inform clinical practice and guidelines for underrepresented populations.

Eligibility

Age: 21 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

* 21 years or older
* Black or white race
* Solid tumor cancer within 3 years of enrollment
* Cannabis use of at least once a week or non cannabis use for 3 months
* experience pain but spend less than 50% in bed or chair
* Prescribed or take opioid for at least 30 days for pain
* Not pregnant or planning to become pregnant in the next 12 months
* English speaking

Exclusion Criteria:

* Lymphoma, leukemia, and melanoma
* CBD only use
* Synthetic cannabis use in past 3 months = Prescribed Medically-prescribed synthetic cannabis (e.g., dronabinol \[Marinol, Syndros\], Epidiolex)
* race other than Black or White

Conditions1

Cancer

Locations3 sites

New York

1 site
University at Buffalo
Buffalo, New York, 14214
Colleen Kilanowski, MS716-829-5977ckk@buffalo.edu

Pennsylvania

2 sites
Thomas Jefferson University
Philadelphia, Pennsylvania, 19144
Brooke Worster, MD215-955-1888Brooke.Worster <Brooke.Worster@jefferson.edu>
University of Pennsylvania
Philadelphia, Pennsylvania, 19176
Andy Robinson215-746-7335arobins2@nursing.upenn.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.